Effects of neurotensin administered into the ventral tegmental area on prepulse inhibition of startle

Behavioural Brain Research

Volumn 106, Issue 1-2, 1999, Pages 189-193

  Feifel, David ^a   Reza, Tammi L ^a  

^a UCSD MEDICAL CENTER   (United States)

Author keywords

Dopamine; Locomotion; Neurotensin; Prepulse inhibition; Startle; Ventral tegmental area

Indexed keywords

NEUROTENSIN;

ACOUSTIC REFLEX; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; LIMBIC SYSTEM; LOCOMOTION; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; STARTLE REFLEX; VENTRAL TEGMENTUM;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; LIMBIC SYSTEM; MALE; MICROINJECTIONS; MOTOR ACTIVITY; NEUROTENSIN; RATS; RATS, SPRAGUE-DAWLEY; STARTLE REACTION; VENTRAL TEGMENTAL AREA;

EID: 0032722868     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(99)00123-0     Document Type: Article

References (28)

1. Blaha CD, Phillips AG. Pharmacological evidence for common mechanisms underlying the effects of neurotensin and neuroleptics on in vivo dopamine efflux in the rat nucleus accumbens. Neuroscience 1992;49:867-77.
2. Boudin H, Pélaprat D, Rostène W, Beaudet A. Cellular distribution of neurotensin receptors in rat brain: immunohistochemical study using an antipeptide antibody against the cloned high affinity receptor. J Comp Neurol 1996;373:76-89.
3. Cador M, Rivet JM, Kelley AE, Le Moal M, Stinus L. Substance P, neurotensin and enkephalin injections into the ventral tegmental area: comparative study on dopamine turnover in several forebrain structures. Brain Res 1989;486:357-63.
4. Druhan JP, Geyer MA, Valentino RJ. Lack of sensitization to the effects of D-amphetamine and apomorphine on sensorimotor gating in rats. Psychopharmacology 1998;135:296-304.
5. Elliott PJ, Nemeroff CB. Repeated neurotensin administration in the ventral tegmental area: effects on baseline and D-amphetamine-induced locomotor activity. Neurosci Lett 1986;68:239-44.
6. Feifel D, Individual differences in pepulse inhibition of startle as a measure of intrinsic dopamine function, Behav. Neurosci. (in press).
7. Feifel D, Minor KL, Dulawa S, Swerdlow NR. The effects of intra-accumbens neurotensin on sensorimotor gating. Brain Res 1997;760:80-4.
8. Feifel D, Reza T, Robeck S. Antipsychotic potential of CCK-based treatments: an assessment using the prepulse inhibition model of psychosis. Neuropsychopharmacology 1999;20:141-9.
9. Glimcher PW, Giovino AA, Hoebel BG. Neurotensin self-injection in the ventral tegmental area. Brain Res 1987;403:147-50.
10. Glimcher PW, Margolin DH, Giovino AA, Hoebel BG. Neurotensin: a new 'reward peptide'. Brain Res 1984;291:119-24.
11. Graham FK. Presidential Address, 1974. The more or less startling effects of weak prestimulation. Psychophysiology 1974;12(1975):238-48.
12. Hökfelt T, Everitt BJ, Theodorsson-Norheim E, Goldstein M. Occurrence of neurotensinlike immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons. J Comp Neurol 1984;222:543-59.
13. Kalivas PW, Burgess SK, Nemeroff CB, Prange AJ Jr. Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat. Neuroscience 1983;8:495-505.
14. Kalivas PW, Miller JS. Neurotensin neurons in the ventral tegmental area project to the medial nucleus accumbens. Brain Res 1984;300:157-60.
15. Kalivas PW, Nemeroff CB, Prange AJ Jr. Increase in spontaneous motor activity following infusion of neurotensin into the ventral tegmental area. Brain Res 1981;229:525-9.
16. Kalivas PW, Nemeroff CB, Prange AJ Jr. Neuroanatomical site specific modulation of spontaneous motor activity by neurotensin. Eur J Pharmacol 1982;78:471-4.
17. Kelley AE, Cador M, Stinus L, Le Moal M. Neurotensin, substance P, neurokinin-alpha, and enkephalin: injection into ventral tegmental area in the rat produces differential effects on operant responding. Psychopharmacology 1989;97:243-52.
18. Kodsi MH, Swerdlow NR. Reduced prepulse inhibition after electrolytic lesions of nucleus accumbens subregions in the rat. Brain Res 1997;773:45-52.
19. Laitinen K, Crawley JN, Mefford IN, De Witte P. Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens. Brain Res 1990;523:342-6.
20. Manberg PJ, Youngblood WW, Nemeroff CB, Rossor MN, Iversen LL, Prange AJ Jr., Kizer JS. Regional distribution of neurotensin in human brain. J Neurochem 1982;38:1777-80.
21. Nemeroff CB, Levant B, Myers B, Bissette G. Neurotensin, antipsychotic drugs, and schizophrenia. Basic and clinical studies. Ann New York Acad Sci 1992;668:146-56.
22. Pellegrino L.J., Pellegrino, A.S., Cushman A.J., A Stereotaxic Atlas of the Rat Brain, 2nd edn., 1979, pp. 35 (122 leaves of plates pp), Plenum Press, New York.
23. Robledo P, Maldonado R, Koob GF. Neurotensin injected into the nucleus accumbens blocks the psychostimulant effects of cocaine but does not attenuate cocaine self-administration in the rat. Brain Res 1993;622:105-12.
24. Shi WX, Bunney BS. Actions of neurotensin: a review of the electrophysiological studies. Ann New York Acad Sci 1992;668:129-45.
25. Sotty F, Soulière F, Brun P, Chouvet G, Steinberg R, Soubrié P, Renaud B, Suaud-Chagny MF. Differential effects of neurotensin on dopamine release in the caudal and rostral nucleus accumbens: a combined in vivo electrochemical and electrophysiological study. Neuroscience 1998;85:1173-82.
26. Swerdlow NR, Braff DL, Taaid N, Geyer MA. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry 1994;51:139-54.
27. Swerdlow NR, Geyer MA. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 1998;24:285-301.
28. Uhl GR, Goodman RR, Snyder SH. Neurotensin-containing cell bodies, fibers and nerve terminals in the brain stem of the rat: immunohistochemical mapping. Brain Res 1979;167:77-91.